Clinical Trials

Overview

About this study

This pilot study will be conducted at Mayo Clinic (Jacksonville) in 10 subjects.  The primary focus of this study will be to assess the pain control following surgery with the utilization of ambit electronic pump through visual analogue scale (VAS), numeric rating scale (NRS), verbal rating scale (VRS), we will assess the fistula over the first few hours and days following the AVF procedure to study the patency of the arteriovenous fistula.

Post-procedure, the patient will receive the pump and instructions for use.  The pump will be used to deliver 0.2% ropivacaine over the indicated 5-day period post-surgery.  Five days was chosen based on the product’s FDA approved indication.  A continuous infusion of 5 cc per hour of 0.2% ropivacaine will be initiated in the recovery room and discontinued on postoperative day 5.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information